“alios-biopharma” Archives

in
Entry Author Date Location
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
Johnson & Johnson Acquires Alios BioPharma for $1,750,000,000 10/01/14 San Francisco
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Alios BioPharma Garners $41,000,000 Series B Funding Round 04/08/14 San Francisco
East Coast Life Sciences Roundup: Vertex, Thermedical, More 11/02/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More 01/26/12 San Diego
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Vertex Pays $60M for Alios Drugs, PKE Acquires Dexela, AisleBuyer Grabs $7.5M, & More Boston-Area Deals News 06/15/11 Boston
Vertex Adds New HepC Drugs for $60M 06/13/11 Boston
Alios BioPharma Lands $32,000,000 Series A Funding Round 06/11/09 San Francisco
Alios BioPharma Garners $8,400,000 Series A Financing 02/09/09 San Francisco
Page 1 of 1